HEALIUS LIMITED — Director's Dealing 2015

Apr 23, 2015

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01 Amended 01/01/11
Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Edmund Gregory Thomas Bateman
Date of last notice	17 April 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	As shown
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.	As shown
Date of change	a) 17 April 2015b) 21 April 2015
No. of securities held prior tochange	506,483Abtourk (Syd No.391) Pty Ltd10,188,251Idameneo (No. 122) Pty Ltd104,836Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman180,000Belinda Carwardine Bateman 756,258 Dr Edmund Bateman11,735,828Ordinary shares
Class	Fully paid ordinary shares
Number acquired	217,938 on 21 April 2015
Number disposed	500,000 on 17 April 2015

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuationNo. of securities held afterchangeNature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	a) 500,000 at $5.30 per shareb) 217,938 at $5.05 per share (DRP)
	515,504Abtourk (Syd No.391) Pty Ltd9,887,531Idameneo (No. 122) Pty Ltd106,703Belinda Carwardine Bateman andEdmund Gregory Thomas Bateman183,206Belinda Carwardine Bateman 760,822 Dr Edmund Bateman11,453,766Ordinary shares
	a) On-market tradeb) Dividend Reinvestment Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest	Not applicable
Name of registered holder	Not applicable
(if issued securities)
Date of change	Not applicable
No. and class of securities to	Not applicable
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	Not applicable
Interest disposed	Not applicable
Value/Consideration	Not applicable
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts Not applicable detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the Not applicable trade to proceed during this period?

If prior written clearance was provided, on what date Not applicable was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011